KT vs. AZN
KT (KT Corporation) and AZN (AstraZeneca PLC) are both stocks. KT operates in Telecom Services (Communication Services), while AZN operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, KT returned 5.93%/yr vs 15.97%/yr for AZN. At a 0.20 correlation, their price movements are largely independent.
Performance
KT vs. AZN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KT achieves a -0.64% return, which is significantly lower than AZN's 1.85% return. Over the past 10 years, KT has underperformed AZN with an annualized return of 5.93%, while AZN has yielded a comparatively higher 15.97% annualized return.
KT
- 1D
- 1.19%
- 1M
- -11.76%
- YTD
- -0.64%
- 6M
- 2.50%
- 1Y
- -3.10%
- 3Y*
- 22.56%
- 5Y*
- 10.32%
- 10Y*
- 5.93%
AZN
- 1D
- 1.04%
- 1M
- 0.32%
- YTD
- 1.85%
- 6M
- 4.25%
- 1Y
- 29.14%
- 3Y*
- 9.91%
- 5Y*
- 11.83%
- 10Y*
- 15.97%
KT vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
KT KT Corporation | -0.64% | 27.73% | 19.93% | 5.01% | 13.34% | 21.00% | -5.09% | -18.42% | -8.90% | 10.79% |
AZN AstraZeneca PLC | 1.85% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
Correlation
The correlation between KT and AZN is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.22 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.18 |
Correlation (All Time) Calculated using the full available price history since May 26, 1999 | 0.20 |
Fundamentals
KT:
$10.39B
AZN:
$286.33B
KT:
$3.14K
AZN:
$6.66
KT:
0.01
AZN:
27.56
KT:
0.00
AZN:
0.04
KT:
0.00
AZN:
4.74
KT:
0.00
AZN:
6.05
KT:
$28.39T
AZN:
$60.44B
KT:
$15.90T
AZN:
$49.37B
KT:
$5.41T
AZN:
$20.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KT vs. AZN — Risk / Return Rank
KT
AZN
KT vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for KT Corporation (KT) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| KT | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.29 | ||
| Sortino ratioReturn per unit of downside risk | -1.94 | ||
| Omega ratioGain probability vs. loss probability | 0.99 | 1.22 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | -0.11 | 1.91 | -2.02 |
| Martin ratioReturn relative to average drawdown | -0.30 | 5.05 | -5.35 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| KT | AZN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.14 | 1.15 | -1.29 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.46 | 0.50 | -0.04 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.26 | 0.64 | -0.39 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.03 | 0.50 | -0.47 |
Drawdowns
KT vs. AZN - Drawdown Comparison
The maximum KT drawdown since its inception was -85.64%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for KT and AZN.
Loading charts...
Drawdown Indicators
| KT | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.64% | -48.94% | -36.70% |
Max Drawdown (1Y)Largest decline over 1 year | -27.30% | -15.43% | -11.87% |
Max Drawdown (3Y)Largest decline over 3 years | -27.30% | -27.87% | +0.57% |
Max Drawdown (5Y)Largest decline over 5 years | -27.30% | -27.87% | +0.57% |
Max Drawdown (10Y)Largest decline over 10 years | -64.03% | -27.87% | -36.16% |
Current DrawdownCurrent decline from peak | -48.22% | -12.00% | -36.22% |
Average DrawdownAverage peak-to-trough decline | -65.89% | -11.37% | -54.52% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.41% | 5.80% | +4.61% |
Volatility
KT vs. AZN - Volatility Comparison
KT Corporation (KT) and AstraZeneca PLC (AZN) have volatilities of 7.40% and 7.49%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KT | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.40% | 7.49% | -0.09% |
Volatility (6M)Calculated over the trailing 6-month period | 16.83% | 17.47% | -0.64% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.95% | 25.51% | -3.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.55% | 24.00% | -1.45% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.34% | 24.91% | -1.57% |
Dividends
KT vs. AZN - Dividend Comparison
KT's dividend yield for the trailing twelve months is around 3.34%, more than AZN's 2.90% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.90% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
KT KT Corporation | 3.34% | 4.24% | 3.50% | 5.29% | 5.40% | 6.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.49% | 1.84% |
Financials
KT vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between KT Corporation and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KT vs. AZN - Profitability Comparison
KT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, KT Corporation reported a gross profit of 2.28T and revenue of 6.98T. Therefore, the gross margin over that period was 32.7%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
KT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, KT Corporation reported an operating income of 492.09B and revenue of 6.98T, resulting in an operating margin of 7.1%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
KT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, KT Corporation reported a net income of 399.91B and revenue of 6.98T, resulting in a net margin of 5.7%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
Frequently Asked Questions
KT and AZN have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AZN has higher volatility (7.49%) compared to KT (7.40%). In terms of maximum drawdown, KT dropped -85.64% vs AZN's -48.94%.
AZN currently has the higher Sharpe Ratio (1.15 vs -0.14), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KT and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer